Recombinant Human FGFR2(IIIb) protein (hFc Tag, Myc Tag, His Tag)

种属

Human

纯度

>90 %, SDS-PAGE

标签

hFc Tag, Myc Tag, His Tag

生物活性

未测试

Cat no : Eg0175

Print datasheet

Synonyms

FGFR2, BEK, BFR 1, CD332, CEK3



产品信息

纯度 >90 %, SDS-PAGE
内毒素 <1.0 EU/μg protein, LAL method
生物活性
Not tested
来源 HEK293-derived Human FGFR2(IIIb) protein Arg22-Glu378 (Accession# P21802-3) with a human IgG1 Fc tag, a Myc tag and a His tag at the C-terminus.
基因ID 2263
蛋白编号 P21802-3
预测分子量 71.1 kDa
SDS-PAGE
组分 Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

FGFR2 (Fibroblast growth factor receptor 2) is a tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration, and apoptosis. Ligand binding leads to the activation of several signaling pathways, such as RAS, MAPK1/ERK2, MAPK3/ERK1, and the MAP Kinase signaling pathway, as well as the AKT1 signaling pathway. Mutations in the gene of FGFR2 are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. This polyclonal antibody raised against 358-704aa of human FGFR2 can cross-react with other members of the FGFR family.

参考文献:

1. Vogel, Arndt et al. Annual review of medicine vol. 74 (2023): 293-306. 2. Goyal, Lipika et al. The New England journal of medicine vol. 388,3 (2023): 228-239. 3. Subbiah, Vivek et al. Cancer discovery vol. 13,9 (2023): 2012-2031. 4. Zingg, Daniel et al. Nature vol. 608,7923 (2022): 609-617.